Actinium Pharmaceuticals Statistics
Total Valuation
ATNM has a market cap or net worth of $31.44 million. The enterprise value is -$3.69 million.
| Market Cap | 31.44M |
| Enterprise Value | -3.69M |
Important Dates
The last earnings date was Friday, August 7, 2026, after market close.
| Earnings Date | Aug 7, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ATNM has 31.44 million shares outstanding. The number of shares has increased by 0.28% in one year.
| Current Share Class | 31.44M |
| Shares Outstanding | 31.44M |
| Shares Change (YoY) | +0.28% |
| Shares Change (QoQ) | +0.54% |
| Owned by Insiders (%) | 0.59% |
| Owned by Institutions (%) | 16.86% |
| Float | 31.25M |
Valuation Ratios
The trailing PE ratio is 2.81.
| PE Ratio | 2.81 |
| Forward PE | n/a |
| PS Ratio | 0.90 |
| Forward PS | n/a |
| PB Ratio | 1.04 |
| P/TBV Ratio | 1.04 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.08, with a Debt / Equity ratio of 0.04.
| Current Ratio | 4.08 |
| Quick Ratio | 3.94 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | 0.13 |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 45.86% and return on invested capital (ROIC) is 23.00%.
| Return on Equity (ROE) | 45.86% |
| Return on Assets (ROA) | 11.58% |
| Return on Invested Capital (ROIC) | 23.00% |
| Return on Capital Employed (ROCE) | 30.93% |
| Weighted Average Cost of Capital (WACC) | 4.20% |
| Revenue Per Employee | $1.30M |
| Profits Per Employee | $418,815 |
| Employee Count | 27 |
| Asset Turnover | 0.68 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -43.82% in the last 52 weeks. The beta is 0.02, so ATNM's price volatility has been lower than the market average.
| Beta (5Y) | 0.02 |
| 52-Week Price Change | -43.82% |
| 50-Day Moving Average | 0.94 |
| 200-Day Moving Average | 1.17 |
| Relative Strength Index (RSI) | 53.29 |
| Average Volume (20 Days) | 185,463 |
Short Selling Information
The latest short interest is 768,504, so 2.44% of the outstanding shares have been sold short.
| Short Interest | 768,504 |
| Short Previous Month | 820,077 |
| Short % of Shares Out | 2.44% |
| Short % of Float | 2.46% |
| Short Ratio (days to cover) | 5.58 |
Income Statement
In the last 12 months, ATNM had revenue of $35.09 million and earned $11.31 million in profits. Earnings per share was $0.36.
| Revenue | 35.09M |
| Gross Profit | 35.09M |
| Operating Income | 9.56M |
| Pretax Income | 11.31M |
| Net Income | 11.31M |
| EBITDA | 9.79M |
| EBIT | 9.56M |
| Earnings Per Share (EPS) | $0.36 |
Balance Sheet
The company has $36.47 million in cash and $1.34 million in debt, with a net cash position of $35.13 million or $1.12 per share.
| Cash & Cash Equivalents | 36.47M |
| Total Debt | 1.34M |
| Net Cash | 35.13M |
| Net Cash Per Share | $1.12 |
| Equity (Book Value) | 30.30M |
| Book Value Per Share | 0.96 |
| Working Capital | 28.48M |
Cash Flow
In the last 12 months, operating cash flow was -$22.66 million and capital expenditures -$584,000, giving a free cash flow of -$23.25 million.
| Operating Cash Flow | -22.66M |
| Capital Expenditures | -584,000 |
| Depreciation & Amortization | 235,000 |
| Net Borrowing | -10,000 |
| Free Cash Flow | -23.25M |
| FCF Per Share | -$0.74 |
Margins
Gross margin is 100.00%, with operating and profit margins of 27.23% and 32.23%.
| Gross Margin | 100.00% |
| Operating Margin | 27.23% |
| Pretax Margin | 32.23% |
| Profit Margin | 32.23% |
| EBITDA Margin | 27.90% |
| EBIT Margin | 27.23% |
| FCF Margin | n/a |
Dividends & Yields
ATNM does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.28% |
| Shareholder Yield | -0.28% |
| Earnings Yield | 35.97% |
| FCF Yield | -73.94% |
Analyst Forecast
The average price target for ATNM is $3.50, which is 250.00% higher than the current price. The consensus rating is "Buy".
| Price Target | $3.50 |
| Price Target Difference | 250.00% |
| Analyst Consensus | Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (3Y) | 801.97% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on August 11, 2020. It was a reverse split with a ratio of 1:30.
| Last Split Date | Aug 11, 2020 |
| Split Type | Reverse |
| Split Ratio | 1:30 |
Scores
ATNM has an Altman Z-Score of -8.41 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -8.41 |
| Piotroski F-Score | 2 |